b

bioMérieux
BIM

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
€13.47B
EV
€13.51B
Shares Outstanding
117.93M
Beta
0.53

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
€124.93
P/E 2025E
24.86x
P/Revenue 2025E
3.13x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About bioMérieux S.A.

gainify

b

bioMérieux S.A.

BIM

bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemica...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Boulud, Pierre

Employees

14,451

IPO Date

2004-07-07

Headquarters

376 Chemin De l’Orme, Marcy-l'Étoile, Rhône-Alpes, 69280, France

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved